United States · FDA National Drug Code directory
hydroxyzine pamoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 14539-675_843627c2-146c-4715-b5b5-8c5c80a8f615
- Product NDC
- 14539-675
- Form
- CAPSULE
- Composition / generic term
- hydroxyzine pamoate
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130603
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROXYZINE PAMOATE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 CONTAINER (14539-675-01) · 14539-675-01
- 500 CAPSULE in 1 CONTAINER (14539-675-05) · 14539-675-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →